Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 12 | Olmstead NathanSVP and CFO | Tax withholding | F | $60K 2,988 sh | Jan 21, 2026 |
| 12 | Milmoe William H.10% Owner | Other acquisition or disposition | J | — 120.0K sh | Jan 21, 2026 traded Jan 20, 2026 |
| 12 | Clark Joseph GatesSVP and Pres, Optimized LED | Tax withholding | F | $51K 2,564 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 12 | Landman YoavDirector, CHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $23K 396 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 12 | Marquez OctavioDirector, President and CEO | Tax withholding | F | $219K 3,136 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 12 | Kuykendall AnneSVP and Chief Legal Officer | Tax withholding | F | $67K 3,379 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 11 | Okupe OluyemiChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $275K 9,067 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 11 | Cree BrianPresident | Open-market sale · 10b5-1 plan | SELL | $28K 1,440 sh | Jan 21, 2026 traded Jan 21, 2026 |
| 11 | Tray ThomasPrincipal Accounting Officer | Grant or award | A | — 2,425 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Audhya Paul K.CHIEF MEDICAL OFFICER | Grant or award | A | — 100.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Small MartinCFO & Senior Managing Director | Option exercise | M | — 27.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Smith DironEVP, Chief Financial Officer | Grant or award | A | — 7,091 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Sweeny NicoleChief Commercial Officer | Grant or award | A | — 100.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Issa Mohamed KhairieEVP, Head of US Oncology | Grant or award | A | — 14.2K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Piekos BrianChief Financial Officer | Grant or award | A | — 100.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Mayes Patrick AEVP & Chief Scientific Officer | Grant or award | A | — 4,218 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 10 | D'Amico AndrewDirector | Open-market sale · 10b5-1 plan | SELL | $31K 200 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 10 | Mat IshbiaDirector, President and CEO, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 6.60M sh | Jan 21, 2026 traded Jan 16, 2026 |
| 9 | Senn AndrewSVP, Strategy and Business Dev | Option exercise | M | — 363 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Moore MichaelPresident | Grant or award | A | — 118.8K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Trahan JeremyGeneral Counsel | Grant or award | A | — 50.4K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Frazier WilliamDirector, Chief Medical Officer | Grant or award | A | — 11.7K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Cambre JeromeVice President of Sales | Grant or award | A | — 10.2K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Fitzgerald TraeChief Financial Officer | Grant or award | A | — 11.7K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Senn AndrewSVP, Strategy and Business Dev | Option exercise | M | — 2,224 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 9 | Trahan JeremyGeneral Counsel | Grant or award | A | — 12.6K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Hoyt CaseyDirector, Chief Executive Officer | Grant or award | A | — 172.2K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Moore MichaelPresident | Grant or award | A | — 29.7K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Frey Anthony GeorgeSVP and Chief Revenue Officer | Tax withholding | F | $12K 610 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 9 | Hoyt CaseyDirector, Chief Executive Officer | Grant or award | A | — 43.0K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Fitzgerald TraeChief Financial Officer | Grant or award | A | — 46.7K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Smith DironEVP, Chief Financial Officer | Option exercise | M | — 1,709 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Bowser Douglas SDirector | Grant or award | A | — 750 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Senn AndrewSVP, Strategy and Business Dev | Option exercise | M | — 363 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Senn AndrewSVP, Strategy and Business Dev | Tax withholding | F | $31K 361 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Vernon CarlaDirector | Grant or award | A | — 750 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Buss Jessica EDirector, Chief Executive Officer | Grant or award | A | — 941.2K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Frazier WilliamDirector, Chief Medical Officer | Grant or award | A | — 2,922 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Cambre JeromeVice President of Sales | Grant or award | A | — 40.7K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 8 | Selecky ChristobelDirector | Option exercise · 10b5-1 plan | M | $149K 50.0K sh | Jan 21, 2026 traded Jan 16, 2026 |